DMAC vs GNRC · $157.4M cap vs P/E 82, rev $4.21B
DiaMedica Therapeutics Inc (DMAC) versus Generac Holdings Inc (GNRC) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Generac Holdings Inc (GNRC) is a specialty industrial machinery company listed on US.
DMAC does not have a complete income-statement cache yet.
Latest reported GNRC revenue for 2025-12-31 was $4.21B. Net income was $159.6M. Revenue was down 2.0% from 2024-12-31 to 2025-12-31. GNRC currently screens at market cap $15.40B and trailing P/E 82.0.
DMAC currently screens at market cap $157.4M. GNRC currently screens at market cap $15.40B and trailing P/E 82.0.
Not investment advice. Open the DMAC and GNRC stock pages for the full models.
Not investment advice.